TaiChi-DTx for Treating Long Covid Symptoms
Unknown statusNot applicableNCT05419219
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The randomized controlled trial will be conducted to evaluate the effectiveness of a Multi-domain Tai Chi Digital Therapy for treating the individuals suffering from the long term COVID-19 syndrome (Long COVID).
Study details
- Official title
- Effectiveness of Multi-domain Tai Chi Digital Therapy for Survivors Affected by the Sequelae of Covid-19 (TaiChi-DTx and Long Covid)
- Conditions
- Fatigue
- Dyspnea
- Cognitive Impairment
- Muscle Pain
- Interventions
- Device: the multi-domain Tai Chi Digital therapy Software Application
- Sponsor
- Tim Shi
- Organization
- GlobalMD Organization Network Corp
- Start date
- 2022-06-01
- Primary completion
- 2023-05-31
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Clinical diagnosis with SARS-CoV2 infection via PCR during the past 3 to 6 months 2. Must be Grade 2 and Grade 3 assessed by the Post-COVID-19 Functional Status (PCFS) Scale Exclusion Criteria: 1. Admitted in the Intensive Care Unit due to SARS-COV2 infection or any other serve illness 2. Psychiatric diseases and somatic co-morbidities 3. COVID-19 infections or co-morbidities started or exacerbated during the same time
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05419219